The long term objectives are as follows: (1) Prepare catalytic monoclonal antibodies (Mabs) that hydrolyze phosphate esters and investigate their biochemical properties. The first successful catalytic Mab that hydrolyzed phosphate esters was prepared during the current funding cycle using a metal-hapten complex. This approach will be expanded in order to examine specificity and diversity of the isolated catalytic Mabs. (2) Develop a high yielding rapid method for synthesizing RNA and dithioate RNA on a polymer support. The approach for synthesizing RNA is built upon a completely orthogonal series of blocking groups including as a key element, a mild acid labile 2'-protecting group and a transient, easily removed 5'-silyl derivative. Using nucleoside H-phosphonothioate synthons, an approach will be developed for synthesizing dithioate RNA. The stability of this linkage toward hydrolysis by various nucleases, including RNase A and ribozymes, and its affinity for proteins such as HIV-RT will be evaluated. (3) Synthesize and evaluate the biochemical properties of new DNA analogs. The synthesis of a new derivative having boranophosphonate internucleotide derivatives will be investigated. Biochemically it will be tested for its ability to activate RNase H and form stable duplexes with complementary RNA and DNA. Another analog having nitrogen in place of the two nonbridging oxygens will also be prepared. Proposed biochemical studies include testing this derivative's ability to form stable duplexes and triplexes with complementary oligonucleotides. Additional research focusing on potential antisense applications will also be completed with dithioate DNA. These studies will include new methods for targeting DNA to cells and evaluation of a new assay for ascertaining antisense activity. (4) Develop methods for synthesizing dithiophosphoryl and boranophosphoryl peptides. Methods will be developed for incorporating these phosphorus derivatives into peptides via a solid phase synthesis strategy. Biochemical evaluation will focus on testing the activity of these phosphopeptides in blocking protein phosphorylation/dephosphorylation events in biological signaling cascades.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Program Officer
Schwab, John M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Colorado at Boulder
Schools of Arts and Sciences
United States
Zip Code
Dellinger, Douglas J; Betley, Jason R; Wyrzykiewicz, Tadeusz K et al. (2005) Synthesis of DNA using a new two-step cycle. Methods Mol Biol 288:1-16
Dellinger, Douglas J; Sheehan, David M; Christensen, Nanna K et al. (2003) Solid-phase chemical synthesis of phosphonoacetate and thiophosphonoacetate oligodeoxynucleotides. J Am Chem Soc 125:940-50
Sierzchala, Agnieszka B; Dellinger, Douglas J; Betley, Jason R et al. (2003) Solid-phase oligodeoxynucleotide synthesis: a two-step cycle using peroxy anion deprotection. J Am Chem Soc 125:13427-41
Sheehan, David; Lunstad, Benjamin; Yamada, Christina M et al. (2003) Biochemical properties of phosphonoacetate and thiophosphonoacetate oligodeoxyribonucleotides. Nucleic Acids Res 31:4109-18
Cummins, L; Graff, D; Beaton, G et al. (1996) Biochemical and physicochemical properties of phosphorodithioate DNA. Biochemistry 35:8734-41
Wengel, J; Schinazi, R F; Caruthers, M H (1995) Stereoselective synthesis, chemistry and antiviral evaluation of 1-(2,3-dideoxy-3-C-hydroxymethyl-beta-D-threo-pentofuranosyl)thymine derivatives. Bioorg Med Chem 3:1223-9
Tonkinson, J L; Guvakova, M; Khaled, Z et al. (1994) Cellular pharmacology and protein binding of phosphoromonothioate and phosphorodithioate oligodeoxynucleotides: a comparative study. Antisense Res Dev 4:269-78
Wiesler, W T; Marshall, W S; Caruthers, M H (1993) Synthesis and purification of phosphorodithioate DNA. Methods Mol Biol 20:191-206
Marshall, W S; Caruthers, M H (1993) Phosphorodithioate DNA as a potential therapeutic drug. Science 259:1564-70
Caruthers, M H; Beaton, G; Wu, J V et al. (1992) Chemical synthesis of deoxyoligonucleotides and deoxyoligonucleotide analogs. Methods Enzymol 211:3-20

Showing the most recent 10 out of 21 publications